Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2025-12-25 @ 4:31 PM
Study NCT ID:
NCT05886257
Status:
WITHDRAWN
Last Update Posted:
2023-06-02
First Post:
2022-12-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
Sponsor:
Shi Ming
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-06
First Submit QC Date:
None
Study First Post Date:
2023-06-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-01
Last Update Post Date:
2023-06-02
Last Update Post Date Type:
ACTUAL